Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 11

1.

Recent advances in pretargeted radioimmunotherapy.

Gruaz-Guyon A, Raguin O, Barbet J.

Curr Med Chem. 2005;12(3):319-38. Review.

PMID:
15723622
2.

Advances in pretargeting biotechnology.

Goodwin DA, Meares CF.

Biotechnol Adv. 2001 Oct;19(6):435-50.

PMID:
14538068
3.

In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.

Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ.

J Nucl Med. 2003 Aug;44(8):1284-92.

4.

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Paganelli G, Chinol M.

Eur J Nucl Med Mol Imaging. 2003 May;30(5):773-6. Epub 2003 Jan 30. No abstract available.

PMID:
12557049
5.

Tools for pretargeted radioimmunotherapy.

Wu AM.

Cancer Biother Radiopharm. 2001 Apr;16(2):103-8. Review. No abstract available.

PMID:
11385957
6.

Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.

Breitz HB, Fisher DR, Goris ML, Knox S, Ratliff B, Murtha AD, Weiden PL.

Cancer Biother Radiopharm. 1999 Oct;14(5):381-95.

PMID:
10850323
7.

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

Knox SJ, Goris ML, Tempero M, Weiden PL, Gentner L, Breitz H, Adams GP, Axworthy D, Gaffigan S, Bryan K, Fisher DR, Colcher D, Horak ID, Weiner LM.

Clin Cancer Res. 2000 Feb;6(2):406-14.

8.

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy.

de Jong M, Bakker WH, Krenning EP, Breeman WA, van der Pluijm ME, Bernard BF, Visser TJ, Jermann E, Béhé M, Powell P, Mäcke HR.

Eur J Nucl Med. 1997 Apr;24(4):368-71.

PMID:
9096086
9.

Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: theoretical and experimental pharmacokinetics.

Sung C, van Osdol WW, Saga T, Neumann RD, Dedrick RL, Weinstein JN.

Cancer Res. 1994 Apr 15;54(8):2166-75.

10.

Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins.

Goodwin D, Meares C, Diamanti C, McCall M, Lai C, Torti F, McTigue M, Martin B.

Eur J Nucl Med. 1984;9(5):209-15.

PMID:
6428891
11.

Investigations of avidin and biotin for imaging applications.

Hnatowich DJ, Virzi F, Rusckowski M.

J Nucl Med. 1987 Aug;28(8):1294-302.

Supplemental Content

Support Center